Molecular Imaging Biomarkers for Early Cancer Detection: A Systematic Review of Emerging Technologies and Clinical Applications

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2024 Nov 9

PMID 39518426

Authors

Maajid Mohi Ud Din Malik

Mansour M Alqahtani

Ibrahim Hadadi

Ibrahem Kanbayti

Zeyad Alawaji

Bader A Aloufi

Affiliations

Soon will be listed here.

Abstract

Background: Early cancer detection is crucial for improving patient outcomes. Molecular imaging biomarkers offer the potential for non-invasive, early-stage cancer diagnosis.

Objectives: To evaluate the effectiveness and accuracy of molecular imaging biomarkers for early cancer detection across various imaging modalities and cancer types.

Methods: A comprehensive search of PubMed/MEDLINE, Embase, Web of Science, Cochrane Library, and Scopus was performed, covering the period from January 2010 to December 2023. Eligibility criteria included original research articles published in English on molecular imaging biomarkers for early cancer detection in humans. The risk of bias for included studies was evaluated using the QUADAS-2 tool. The findings were synthesized through narrative synthesis, with quantitative analysis conducted where applicable.

Results: In total, 50 studies were included. Positron emission tomography (PET)-based biomarkers showed the highest sensitivity (mean: 89.5%, range: 82-96%) and specificity (mean: 91.2%, range: 85-100%). Novel tracers such as [Ga]-PSMA for prostate cancer and [F]-FES for breast cancer demonstrated promising outcomes. Optical imaging techniques showed high specificity in intraoperative settings.

Conclusions: Molecular imaging biomarkers show significant potential for improving early cancer detection. Integration into clinical practice could lead to earlier interventions and improved outcomes. Further research is needed to address standardization and cost-effectiveness.

Citing Articles

Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance.

Fasulo E, DAmico F, Zilli A, Furfaro F, Cicerone C, Parigi T Cancers (Basel). 2025; 17(1.

PMID: 39796690 PMC: 11718813. DOI: 10.3390/cancers17010060.

References

Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y . Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci. 2020; 7:193. PMC: 7468194. DOI: 10.3389/fmolb.2020.00193. View

Jain M, Narula N, Salamoon B, Shevchuk M, Aggarwal A, Altorki N . Full-field optical coherence tomography for the analysis of fresh unstained human lobectomy specimens. J Pathol Inform. 2013; 4:26. PMC: 3814996. DOI: 10.4103/2153-3539.119004. View

Frilling A, Clift A, Braat A, Alsafi A, Wasan H, Al-Nahhas A . Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis. HPB (Oxford). 2019; 21(7):773-783. DOI: 10.1016/j.hpb.2018.12.014. View

Fendler W, Rahbar K, Herrmann K, Kratochwil C, Eiber M . Lu-PSMA Radioligand Therapy for Prostate Cancer. J Nucl Med. 2017; 58(8):1196-1200. DOI: 10.2967/jnumed.117.191023. View

Fraum T, Fowler K, McConathy J, Parent E, Dehdashti F, Grigsby P . PET/MRI for the body imager: abdominal and pelvic oncologic applications. Abdom Imaging. 2015; 40(6):1387-404. DOI: 10.1007/s00261-015-0390-3. View

Hofman M, Lawrentschuk N, Francis R, Tang C, Vela I, Thomas P . Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020; 395(10231):1208-1216. DOI: 10.1016/S0140-6736(20)30314-7. View

Jiang S, Yang T, Zou Q, Xu L, Ye T, Kang Y . The role of Tc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with Tc-MIBI planar scintigraphy and ultrasonography. BMC Med Imaging. 2020; 20(1):115. PMC: 7565325. DOI: 10.1186/s12880-020-00517-9. View

Wilson K, Wang T, Willmann J . Acoustic and photoacoustic molecular imaging of cancer. J Nucl Med. 2013; 54(11):1851-4. PMC: 4084699. DOI: 10.2967/jnumed.112.115568. View

Zhao Y, Mastanduno M, Jiang S, Ei-Ghussein F, Gui J, Pogue B . Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast. J Biomed Opt. 2015; 20(5):56009. PMC: 4572095. DOI: 10.1117/1.JBO.20.5.056009. View

10.

Gambhir S . Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002; 2(9):683-93. DOI: 10.1038/nrc882. View

11.

Cui X, Ignee A, Jedrzejczyk M, Dietrich C . Dynamic Vascular Pattern (DVP), a quantification tool for contrast enhanced ultrasound. Z Gastroenterol. 2013; 51(5):427-31. DOI: 10.1055/s-0032-1325371. View

12.

Yordanova A, Eppard E, Kurpig S, Bundschuh R, Schonberger S, Gonzalez-Carmona M . Theranostics in nuclear medicine practice. Onco Targets Ther. 2017; 10:4821-4828. PMC: 5633297. DOI: 10.2147/OTT.S140671. View

13.

Stummer W, Pichlmeier U, Meinel T, Wiestler O, Zanella F, Reulen H . Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7(5):392-401. DOI: 10.1016/S1470-2045(06)70665-9. View

14.

Giovanella L, Avram A, Iakovou I, Kwak J, Lawson S, Lulaj E . EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging. 2019; 46(12):2514-2525. DOI: 10.1007/s00259-019-04472-8. View

15.

Kircher M, Hricak H, Larson S . Molecular imaging for personalized cancer care. Mol Oncol. 2012; 6(2):182-95. PMC: 5528375. DOI: 10.1016/j.molonc.2012.02.005. View

16.

Hoffmann M, Wieler H, Baues C, Kuntz N, Richardsen I, Schreckenberger M . The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer. Urology. 2019; 130:1-12. DOI: 10.1016/j.urology.2019.04.004. View

17.

Kiesslich R, Goetz M, Lammersdorf K, Schneider C, Burg J, Stolte M . Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology. 2007; 132(3):874-82. DOI: 10.1053/j.gastro.2007.01.048. View

18.

Mayerhoefer M, Prosch H, Beer L, Tamandl D, Beyer T, Hoeller C . PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations. Eur J Nucl Med Mol Imaging. 2019; 47(1):51-60. PMC: 6885019. DOI: 10.1007/s00259-019-04452-y. View

19.

Pichler B, Kolb A, Nagele T, Schlemmer H . PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med. 2010; 51(3):333-6. DOI: 10.2967/jnumed.109.061853. View

20.

Gallagher F, Woitek R, McLean M, Gill A, Manzano Garcia R, Provenzano E . Imaging breast cancer using hyperpolarized carbon-13 MRI. Proc Natl Acad Sci U S A. 2020; 117(4):2092-2098. PMC: 6995024. DOI: 10.1073/pnas.1913841117. View